Topic: Clinical Trial

The FDA’s new draft guidance on Decentralized Clinical Trials (DCTs) is a landmark moment for […]

MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to […]

NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 […]

Ancora Heart announced that it entered into a strategic partnership with Egnite to accelerate clinical trial […]

Tandem Diabetes Care (Nasdaq:TNDM) today announced a positive meta-analysis of three randomized controlled trials of its […]

Alentis Therapeutics, a biotech pursuing a novel target as a way of treating fibrosis and […]

Cardiovascular Systems (NASDAQ: CSII)+ this week announced it completed enrollment in its Eclipse coronary trial. The company […]

Endotronix announced today that it completed enrollment for a trial evaluating its Cordella pulmonary artery (PA) […]

Vaxxas today announced clinical trial data demonstrating the potential of its high-density microarray patch (HD-MAP) […]

Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led […]

Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B […]

Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is […]

ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralized clinical trial with a […]

Stratus Medical has announced the first patient enrolled in the COBRA study, a double-blinded, randomized […]

Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of […]

Premia Spine has announced the publication of two-year outcomes from the TOPS facet joint replacement […]

Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns […]

hbbAmong Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet […]

A randomized, triple-blinded clinical trial involving 35 women has found that active transcranial direct current […]

Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that […]

Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of […]

Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes […]

One challenge of developing a drug for a disease with no approved therapies is that […]

Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes […]

A double-blinded randomized controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) […]

OstomyCure announced today that it completed patient recruitment in the pivotal clinical trial of its […]

Medtronic (NYSE:MDT) today announced that it enrolled the first patient in a head-to-head trial of aortic […]

Inari Medical (Nasdaq:NARI) today announced that it enrolled the first patient in its Defiance trial for […]

Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results […]

A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts […]

Combination therapies are a mainstay of cancer care, the idea being that treatments that work […]

Real-world data startup Crescendo Health launched Thursday with $3.4 million from Define Ventures and other […]

Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy […]

Abbott has announced the US Food and Drug Administration (FDA) approval of the company’s Eterna […]

Empirical Spine has revealed that it has recently completed the final step in the US […]

Congress passed the FDA Modernization Act 2.0 last week removing the requirement to use animal […]

Frontotemporal dementia (FTD) or frontotemporal lobar degeneration (FTLD) is a rare, rapidly progressing neurodegenerative disease […]

Dive Brief: The investment arms of billionaires Jeff Bezos and Bill Gates joined a $75 […]

Corvia Medical announced that it randomized the first patient in its Responder-HF global confirmatory trial of […]